Jump to navigation

The University of Arizona Wordmark Line Logo White
UA Profiles | Home
  • Phonebook
  • Edit My Profile
  • Feedback

Profiles search form

Kresimira M Milas

  • Professor, Surgery - (Clinical Scholar Track)
  • Division Chief, Endocrine Surgery
  • Academic Vice Chair, Academic Affairs and Faculty Development
Contact
  • (602) 521-5969
  • Biosciences Partnership Phx, Rm. E972A
  • Phoenix, AZ 85004
  • mmilas@arizona.edu
  • Bio
  • Interests
  • Courses
  • Scholarly Contributions

Degrees

  • M.D. Medicine
    • University of Texas McGovern Medical School, Houston, Texas, United States

Awards

  • Please see extended list in CV
    • Spring 2019
  • Patient Satisfaction top scores
    • InMoment/Net Promoter Scores highest among 159faculty at BUMCP Ambulatory Clinics, Winter 2018
  • Top 10 Lectures Award
    • UACOM-Phoenix Medical Students for Surgery Clerkship, Winter 2018
  • ASA
    • American Surgical Association, Spring 2017
  • Dean
    • AAES, Spring 2017

Related Links

Share Profile

Interests

Teaching

Endocrine Surgery, Thyroid, Parathyroid, Adrenal, Hereditary Cancer Syndromes

Research

Molecular markers for thyroid cancer diagnosis, parathyroid diseases, PTEN

Courses

No activities entered.

Scholarly Contributions

Books

  • More info
    This text provides a comprehensive review of ultrasound in thyroid and parathyroid diseases. These topics are presented from a vantage point of complex decision-making encountered in real clinical scenarios. The sections are organized according to a logical structure covering benign and malignant thyroid conditions, parathyroid disease, and ultrasound technology, ultrasound-guided interventions, and innovations. The style of the chapters provide practical, actionable information that is richly illustrated with figures and links to video cine-clips. The chapter topics aim to show how different specialists uniquely apply ultrasound in given clinical scenarios. The text illustrates the optimal incorporation of current practice guidelines, as this remains varied and inconsistent among clinicians. The content is written by invited experts who perform ultrasound in their daily clinical practices and participate in teaching ultrasound nationally and internationally. It conveys the most up-to-date scientific and clinical information in an interactive and visual format. Advanced Thyroid and Parathyroid Ultrasound fills a gap in currently available resources by serving as a single resource unifying information relevant to multiple specialists interested in advanced thyroid and parathyroid ultrasound. It provides a practical, concise yet comprehensive summary of the current status of the field that will help guide patient management.

Chapters

Journals/Publications

  • More info
    Amiodarone is a class III antiarrhythmic drug, used by cardiologists to treat arrhythmia including atrial fibrillation (A fib) and ventricular fibrillation. However, amiodarone is associated with endocrine dysfunction including both hypo- and hyperthyroidism. In the literature, two types of amiodarone-induced thyrotoxicosis (AIT) were described: AIT-1 and AIT-2. Mixed AIT also called AIT type 3 (AIT-3) has been described in the literature when the cases do not have a typical presentation. In order to differentiate different types of AIT, various clinical, biochemical, and radiological tools have been proposed. The use of 99mTc-methoxy-isobutyl-isonitrile (sestaMIBI) uptake on scintigraphy (99m-STS) has been suggested in the literature in only few studies (no large retrospective or prospective studies have been established in the United States). We present a case series describing 5 patients presenting to the University of Arizona with AIT where we used 99m-STS to assess in diagnosis and treatment of different types of AIT followed by a review of the literature.

Presentations

Reviews

Creative Productions

Profiles With Related Publications

  • Jennifer F Preston
  • Gamal F Sidarous

 Edit my profile

UA Profiles | Home

University Information Security and Privacy

© 2025 The Arizona Board of Regents on behalf of The University of Arizona.